Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.
Başaran Ö, Dogan V, Beton O, Tekinalp M, Aykan AÇ, Kalaycıoğlu E, Bolat I, Taşar O, Şafak Ö, Kalçık M, Yaman M, İnci S, Altıntaş B, Kalkan S, Kırma C, Biteker M; and Collaborators.
Başaran Ö, et al. Among authors: kalcik m.
J Thromb Thrombolysis. 2017 Feb;43(2):157-165. doi: 10.1007/s11239-016-1445-1.
J Thromb Thrombolysis. 2017.
PMID: 27848065
Clinical Trial.